← Concord Medical Services Holdings Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $65.5m |
$50.9m
-22.38%
|
$27.8m
-45.42%
|
$28.5m
+2.62%
|
$34.2m
+19.95%
|
$76.2m
+122.97%
|
$68.4m
-10.18%
|
$75.7m
+10.58%
|
$52.6m
-30.50%
|
$65.9m
+25.19%
|
$460.5m
+599.32%
|
|
| Cost of Goods and Services Sold | $41.3m |
$35.8m
-13.24%
|
$24.9m
-30.49%
|
$14.9m
-40.03%
|
$19.4m
+29.82%
|
$51.7m
+166.74%
|
$48.5m
-6.15%
|
$54.5m
+12.37%
|
$38.1m
-30.02%
|
$62.2m
+62.94%
|
$434.7m
+599.31%
|
|
| Gross Profit | $24.3m |
$15.1m
-37.93%
|
$2.9m
-80.92%
|
($2.3m)
-179.12%
|
$2.0m
+188.17%
|
($8.9m)
-545.34%
|
($22.1m)
-147.47%
|
($10.8m)
+51.17%
|
($10.8m)
-0.51%
|
$3.7m
+134.04%
|
$25.8m
+599.32%
|
|
| General and Administrative Expense | $29.7m | $36.5m | $42.4m | $45.3m | $45.2m | $54.6m | $45.1m | $46.5m | $55.4m | $30.5m | $213.0m | |
| Amortization of Intangible Assets | $1.6m | $957k | $605k | $1.7m | $2.4m | $4.7m | $5.0m | $5.2m | $5.0m | $5.2m | — | |
| Operating Lease, Lease Income | — | — | — | $7.7m | $7.0m | $5.6m | $2.6m | $1.9m | $920k | $452k | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | ($24.3m) |
($32.6m)
-34.07%
|
($43.5m)
-33.67%
|
($62.8m)
-44.32%
|
($48.4m)
+22.90%
|
($71.9m)
-48.51%
|
($76.1m)
-5.85%
|
($65.2m)
+14.34%
|
($72.9m)
-11.80%
|
($37.4m)
+48.71%
|
($239.3m)
-540.04%
|
|
| Interest Expense | $12.9m | $13.8m | $6.7m | $4.1m | $12.5m | $11.6m | $17.4m | $23.3m | — | — | $152.3m | |
| Interest Expense, Debt | — | $19.3m | $6.7m | $7.6m | $12.5m | $11.6m | $17.4m | $23.3m | $26.5m | $21.8m | $152.3m | |
| Foreign Currency Transaction Gain (Loss), before Tax | $1.9m | $618k | $5.3m | $5.0m | ($9.0m) | ($3.1m) | $8.0m | $1.4m | ($2.4m) | ($1.7m) | — | |
| Gain (Loss) on Investments | — | — | — | — | — | — | — | — | $999k | $0 | — | |
| Other Nonoperating Income (Expense) | $2.6m | $444k | $5.0m | $5.3m | $967k | ($192k) | ($31.4m) | ($1.5m) | ($1.3m) | ($1.1m) | — | |
| Income (Loss) from Equity Method Investments | $89k | $223k | ($3.0m) | ($729k) | $923k | $2.9m | $2.6m | $2.9m | $1.7m | $1.9m | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $26.5m | $21.8m | $152.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($9.1m) | ($9.3m) | $18.4m | ($37.9m) | ($45.8m) | ($83.9m) | ($128.3m) | ($81.2m) | ($86.7m) | ($56.2m) | ($373.4m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($29.5m) | ($39.0m) | $32.8m | $56.2m | $67.7m | $83.0m | $121.8m | $78.3m | ($91.7m) | — | ($373.4m) | |
| Current Income Tax Expense (Benefit) | $3.7m | $785k | $6.3m | ($2.4m) | ($3.7m) | $646k | ($1.3m) | ($988k) | ($311k) | $2.0m | $6.1m | |
| Income Tax Expense (Benefit) | $8.7m | $4.9m | $5.0m | ($5.6m) | ($5.8m) | ($1.0m) | ($10.3m) | ($3.5m) | ($2.4m) | $867k | $6.1m | |
| Net Income (Loss) Attributable to Parent | ($37.7m) |
($43.7m)
-15.86%
|
($34.2m)
+21.82%
|
($44.1m)
-29.11%
|
($47.5m)
-7.72%
|
($42.6m)
+10.35%
|
($71.0m)
-66.67%
|
($41.9m)
+40.94%
|
($42.2m)
-0.72%
|
($13.3m)
+68.57%
|
($92.8m)
-599.35%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | ($52.2m) |
($79.4m)
-51.90%
|
($102.7m)
-29.36%
|
($128.8m)
-25.43%
|
($71.0m)
+44.87%
|
($41.9m)
+40.94%
|
($42.2m)
-0.72%
|
($13.3m)
+68.57%
|
($92.8m)
-599.35%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | ($463k) | ($210k) | ($3.6m) | ($6.5m) | ($14.4m) | ($39.4m) | ($40.5m) | ($32.9m) | ($47.1m) | ($41.0m) | ($92.8m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | ($0) | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | ($0) | — | — | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | ($0.29) | — | — | — | — | — | ($0.54) | ($0.32) | ($0.32) | ($0.10) | ($21.30) | |
| Earnings Per Share, Diluted | ($0.29) | — | — | — | — | — | ($0.54) | ($0.32) | ($0.32) | ($0.10) | ($21.30) | |
| Weighted Average Number of Shares Outstanding, Basic | 130.6m | — | — | — | — | — | 131.1m | 131.1m | 131.1m | 131.1m | 4.4m | |
| Weighted Average Number of Shares Outstanding, Diluted | 130.6m | — | — | — | — | — | 131.1m | 131.1m | 131.1m | 131.1m | 4.4m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $22.2m | |
| Lease Income | — | — | $11.2m | $8.4m | — | — | — | — | — | — | — | |
| Selling Expense | $10.1m | $6.7m | $3.2m | $4.3m | $3.9m | $8.4m | $8.9m | $7.9m | $6.7m | $7.5m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | ($37.7m) | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | ($38.2m) | ($43.9m) | ($37.7m) | ($50.6m) | ($61.9m) | ($82.0m) | ($111.5m) | ($74.8m) | ($89.3m) | ($54.3m) | — |